Lucid Diagnostics Inc.
General ticker "LUCD" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $51.7M (TTM average)
Lucid Diagnostics Inc. does not follow the US Stock Market performance with the rate: -4.5%.
Estimated limits based on current volatility of 2.4%: low 1.01$, high 1.06$
Factors to consider:
- Total employees count: 70 (-5.4%) as of 2023
- Top business risk factors: Operational and conduct risks, Limited operating history, Labor/talent shortage/retention, Product specific risks, Geopolitical risks
- Price in estimated range
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.78$, 2.05$]
- 2024-12-30 to 2025-12-30 estimated range: [0.67$, 1.79$]
Financial Metrics affecting the LUCD estimates:
- Positive: with PPE of -1.5 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -56.86 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of -8.47 <= 18.93
- Positive: Inventory ratio change, % of -44.07 <= -0.75
- Positive: Industry inventory ratio change (median), % of -0.08 <= 0
- Positive: Interest expense per share per price, % of 0.72 <= 0.79
Short-term LUCD quotes
Long-term LUCD plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.50MM | $0.38MM | $2.43MM |
| Operating Expenses | $27.92MM | $56.55MM | $50.91MM |
| Operating Income | $-27.42MM | $-56.17MM | $-48.48MM |
| Non-Operating Income | $-0.66MM | $0.00MM | $-4.18MM |
| Interest Expense | $0.66MM | $0.00MM | $0.42MM |
| R&D Expense | $9.30MM | $11.47MM | $7.25MM |
| Income(Loss) | $-28.08MM | $-56.17MM | $-52.67MM |
| Profit(Loss)* | $-28.08MM | $-56.17MM | $-52.67MM |
| Stockholders Equity | $54.74MM | $23.05MM | $-2.31MM |
| Inventory | $0.49MM | $0.11MM | $0.28MM |
| Assets | $59.00MM | $32.51MM | $27.27MM |
| Operating Cash Flow | $-17.67MM | $-29.68MM | $-32.82MM |
| Capital expenditure | $0.86MM | $0.91MM | $0.22MM |
| Investing Cash Flow | $-0.86MM | $-4.11MM | $-0.22MM |
| Financing Cash Flow | $72.08MM | $2.61MM | $29.46MM |
| Earnings Per Share** | $-0.78 | $-1.55 | $-1.26 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.